摘要
目的探讨超声引导射频消融术对肾癌患者的临床应用价值。方法对17例肾癌患者18个病灶先行超声引导下穿刺活检,然后在超声引导下对病灶进行射频消融。结果 14例病理为肾透明细胞癌,1例为乳头状肾细胞癌,2例未活检。17个病灶一次性完全消融;1个病灶出现残留,3个月后行二次消融完全。所有患者术后均未出现明显并发症。结论超声引导射频消融肾癌具有创伤小,定位精确,消融范围可控,治疗时间短,术后恢复快,可重复消融等优点,是外科手术的良好补充。
Objective To explore the clinic value of ultrasound-guided radiofrequency ablation （RFA） to renal cell carci noma. Methods Ultrasound-guided biopsy was performed to 17 patients of renal cell carcinoma with 18 nodes, and then radio- frequency ablation therapy was utilized. Results The pathology diagnosis of 14 patients was clear cell carcinoma, one case was papilary carcinoma, and two cases didn＇t get bioPsy. 17 lesions were completely melt in radiofrequency ablation surgery for the first time. In one case, residual disease was found out after the 1st time therapy, and was completely melt after the 2nd time therapy. No patient had obvious complications after the RFA. Conclusion Ultrasound-guided radiofrequency ablation is a good supplement to surgical procedure, as it has the merits of small wound, precise positioning, manageable RFA range, short dura tion of therapy, early recovery and repeatable ablation.
出处
《福建医药杂志》
CAS
2014年第2期106-108,共3页
Fujian Medical Journal
关键词
肾细胞癌
射频消融
超声引导
renal cell carcinoma
radiofrequency ablation
ultrasound guidance
